2016 Annual Meeting

Pulmonary Pathology Society

Room CC Ballroom 6 A, March 12 2016, 7:00pm to 10:00pm

Description

Pulmonary Pathology Society

Emerging Topics in Pulmonary Pathology

Saturday, March 12, 2016
7:00 PM 10:00 PM
CC Ballroom 6 A

Moderators: Kirtee Raparia, MD, Northwestern University, Chicago, IL
Keith M. Kerr, MD, Aberdeen University School of Medicine, Aberdeen, Scotland

Course Description:
Emerging areas in lung pathology include liquid biopsy (circulating tumor cells and cell free DNA) in patient plasma for lung cancer diagnostics and biomarker testing, immuno-oncology biomarker testing for immune checkpoint inhibitor therapy, cryobiopsy as a modality for diagnosing interstitial lung diseases without surgical biopsy and new multidisciplinary approaches to diagnosing interstitial lung diseases and new targeted therapies for these diseases. The technology and knowledge in these topics are embryonic but rapidly developing, creating a need for education and update in these fields for practicing pathologists. This program addresses each of these emerging topics as described in the objectives.

Upon completion of this educational activity, participants should be able to:

  1. Discuss recent developments in lung cancer targeted therapy and companion diagnostics including liquid biopsy and immuno-oncology.
  2. Appreciate how cryobiopsy is done, what the complications are, and its usefulness in ILD.
  3. Understand the importance of combining of pathologic, radiologic, and clinical evidence in the diagnosis of interstitial lung diseases and discuss the therapeutic and prognostic implications of these diagnoses.
  4. Comprehend the current evidence supporting use of new “targeted” therapies in idiopathic pulmonary fibrosis and other fibrosing lung diseases, and the rationales for the agents currently being evaluated in clinical trials.

7:00 PM

Welcome
Donald Guinee, MD, Virginia Mason Medical Center, Seattle, WA

7:05 PM

Introduction
Aliya N. Husain, MD, University of Chicago, Chicago, IL

7:15 PM

New Frontiers in Lung Cancer Diagnostics
Ming S. Tsao, MD, University of Toronto, University Health Network, Toronto, Ontario, Canada

8:00 PM

Interstitial Lung Diseases: Why the Diagnosis Matters
Lida P. Hariri, MD, PhD, Wellman Center for Photo-medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Lynette Sholl, MD, Brigham and Women’s Hospital, Boston, MA
Sydney B. Montesi, MD, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA

9:00 PM Cryobiopsy for Interstitial Lung Disease
Thomas V. Colby, MD, Mayo Clinic, Scottsdale, AZ
Sara Tomassetti, MD, GB Morgagni Hospital, Forli, Italy

Meetings

home-circle-inset-1
view more